🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquarePCOS and GLP-1 agonists — reproductive outcomes data

PCOS and GLP-1 agonists — reproductive outcomes data

MeganSA_TX Sat, Mar 28, 2026 at 6:28 AM 17 replies 787 viewsPage 1 of 4
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Mar 28, 2026 at 6:28 AM#1

This gets cited here weekly, usually second-hand, so it is worth setting out what it does and does not establish.

The class is not used in pregnancy, and the practical points are a washout before conception and the fact that reduced appetite is not contraception. Improved insulin sensitivity in PCOS can restore ovulation, so fertility frequently increases as a side effect — people conceive unexpectedly on these drugs, which is a reason to sort contraception out at the start rather than after.

Where I think it is weakest: the subgroup findings are the part I trust least — with enough subgroups something is always significant, and these were not all pre-registered.

The question I want answered is what the washout thinking is before trying to conceive, and why nobody mentions that fertility often increases as a side effect. Not looking for reassurance. Looking for the part I have got wrong.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
42 12PharmD_Rodriguez, julia.endo, JessicaM_2024 and 39 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Mar 28, 2026 at 6:35 AM#2
MeganSA_TX said:
The class is not used in pregnancy, and the practical points are a washout before conception and the fact that reduced appetite is not contraception.
MeganSA_TX said:
...everyone should be on fertility and pregnancy...

I understand the enthusiasm, but "everyone" is too broad. Contraindications exist: personal/family history of MTC or MEN2, history of pancreatitis, pregnancy/breastfeeding, and certain GI conditions.

Beyond contraindications, clinical judgment matters. A 22-year-old with BMI 28 and no comorbidities has a different risk-benefit calculation than a 55-year-old with BMI 38 and metabolic syndrome.

Let's advocate for ACCESS without advocating for UNIVERSAL use. They're different things.

Last edited: Mar 28, 2026 at 9:35 AM
41 11VanRx_Mike, steve_okc, dave_SLC and 38 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Mar 28, 2026 at 6:42 AM#3
MeganSA_TX said:
The class is not used in pregnancy, and the practical points are a washout before conception and the fact that reduced appetite is not contraception.

I read this differently from MeganSA_TX, on substance rather than tone. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

40 10AussieAnna, BethLabQueen, ChrisMacros and 37 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Mar 28, 2026 at 6:49 AM#4

Short answer first, then the reasoning. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

39 9Dr.PeteFamMed, claudia_zurich, nancy_portland and 36 others
Reply Quote Save Share Report
marco_milano
Member
345
1,456
Jul 2024
Milan, IT
Mar 28, 2026 at 7:25 AM#5
kate.chem said:
MeganSA_TX said: ...everyone should be on fertility and pregnancy...

Mine went the same way, slower. The detail I would add is minor and it is already implied above.

Last edited: Mar 28, 2026 at 11:25 AM
38 8emma_london, tammy_FL, Dr.LipidDallas and 35 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register